Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 39% ± 17% | |
glutamatergic neuron | 11 studies | 49% ± 22% | |
oligodendrocyte precursor cell | 11 studies | 40% ± 15% | |
GABAergic neuron | 9 studies | 49% ± 20% | |
neuron | 6 studies | 36% ± 20% | |
interneuron | 6 studies | 54% ± 17% | |
retinal cone cell | 6 studies | 60% ± 27% | |
cardiac muscle cell | 6 studies | 74% ± 18% | |
retinal rod cell | 4 studies | 61% ± 15% | |
endothelial cell | 3 studies | 45% ± 19% | |
GABAergic interneuron | 3 studies | 55% ± 12% | |
Purkinje cell | 3 studies | 64% ± 25% | |
epithelial cell | 3 studies | 41% ± 10% | |
progenitor cell | 3 studies | 39% ± 14% | |
amacrine cell | 3 studies | 39% ± 22% | |
adipocyte | 3 studies | 24% ± 5% | |
GABAergic amacrine cell | 3 studies | 46% ± 7% | |
neural progenitor cell | 3 studies | 33% ± 14% | |
ciliated cell | 3 studies | 36% ± 7% | |
smooth muscle cell | 3 studies | 30% ± 9% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 59% ± 30% | |
renal principal cell | 3 studies | 50% ± 25% | |
myoepithelial cell | 3 studies | 51% ± 31% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 99% | 1383.11 | 88 / 89 | 96% | 12.62 | 864 / 901 |
adrenal gland | 100% | 3208.19 | 258 / 258 | 92% | 28.13 | 212 / 230 |
prostate | 97% | 2340.57 | 238 / 245 | 90% | 7.95 | 451 / 502 |
brain | 78% | 862.69 | 2055 / 2642 | 95% | 10.41 | 667 / 705 |
skin | 90% | 787.37 | 1627 / 1809 | 80% | 10.31 | 376 / 472 |
bladder | 90% | 1335.62 | 19 / 21 | 62% | 4.78 | 310 / 504 |
breast | 75% | 777.10 | 345 / 459 | 67% | 4.17 | 749 / 1118 |
esophagus | 88% | 1323.09 | 1267 / 1445 | 45% | 4.66 | 82 / 183 |
intestine | 82% | 885.03 | 796 / 966 | 37% | 1.62 | 196 / 527 |
ovary | 93% | 743.61 | 168 / 180 | 26% | 1.08 | 111 / 430 |
blood vessel | 99% | 2120.21 | 1328 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 2870.56 | 798 / 803 | 0% | 0 | 0 / 0 |
uterus | 38% | 238.91 | 64 / 170 | 61% | 6.05 | 281 / 459 |
heart | 95% | 8373.52 | 821 / 861 | 0% | 0 | 0 / 0 |
thymus | 38% | 181.37 | 251 / 653 | 50% | 3.00 | 301 / 605 |
pancreas | 1% | 3.38 | 2 / 328 | 74% | 4.71 | 132 / 178 |
stomach | 31% | 218.72 | 111 / 359 | 38% | 1.85 | 108 / 286 |
tonsil | 0% | 0 | 0 / 0 | 67% | 7.58 | 30 / 45 |
lung | 13% | 70.03 | 75 / 578 | 54% | 4.82 | 619 / 1155 |
eye | 0% | 0 | 0 / 0 | 54% | 3.54 | 43 / 80 |
adipose | 37% | 243.92 | 445 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 1.42 | 1 / 226 | 15% | 1.09 | 62 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.15 | 2 / 29 |
peripheral blood | 5% | 60.50 | 51 / 929 | 0% | 0 | 0 / 0 |
spleen | 3% | 14.60 | 8 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045214 | Biological process | sarcomere organization |
GO_0030866 | Biological process | cortical actin cytoskeleton organization |
GO_0055003 | Biological process | cardiac myofibril assembly |
GO_0005856 | Cellular component | cytoskeleton |
GO_0030018 | Cellular component | Z disc |
GO_0005737 | Cellular component | cytoplasm |
GO_0051015 | Molecular function | actin filament binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FHOD3 |
Protein name | Formin homology 2 domain containing 3 FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2) |
Synonyms | FHOS2 KIAA1695 |
Description | FUNCTION: Actin-organizing protein that may cause stress fiber formation together with cell elongation (By similarity). Isoform 4 may play a role in actin filament polymerization in cardiomyocytes. . |
Accessions | Q2V2M9 ENST00000359247.8 [Q2V2M9-1] ENST00000257209.8 [Q2V2M9-3] ENST00000592930.5 K7EP24 K7ER94 ENST00000590592.6 [Q2V2M9-4] ENST00000585579.2 A0A0A0MTS9 ENST00000592128.5 ENST00000591635.5 K7EKZ0 |